Both Tirzepatide and this treatment represent innovative methods to managing glucose control, and increasingly, obesity. Semaglutide is a combined receptor activator that impacts multiple chemicals involved in metabolism: the incretin hormone and GIP. It, often seen as a trade name for Semaglutid